Italia markets closed

BMY Jan 2025 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,2500-0,0500 (-1,16%)
Alla chiusura: 01:19PM EDT
Schermo intero
Chiusura precedente4,3000
Aperto4,1500
Denaro4,1000
Lettera4,2000
Prezzo d'esercizio45,00
Scadenza2025-01-17
Min-Max giorno4,1300 - 4,3000
Contratto - Min-MaxN/D
Volume26
Open Interest8,3k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri